Details of the Drug Formulaction

General Information of Drug Formulation (ID: F14835)

• Formulation Name: Nadolol 40 mg tablet
• Company: Camber Pharmaceuticals; Cipla

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nadolol	(DMW6GVL)	Angina pectoris	BA40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Quinoline yellow WS	(E00309)	24671	Colorant